PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung ; day:12 ; month:2 ; year:2021 ; pages:1-11
Cancer immunology immunotherapy ; (12.2.2021), 1-11
- Urheber
-
Goldmann, Torsten
Marwitz, Sebastian
Nitschkowski, Dörte
Krupar, Rosemarie
Backman, Max
Elfving, Hedvig
Thurfjell, Viktoria
Lindberg, Amanda
Brunnström, Hans
Fleur, Linnea La
Mezheyeuski, Artur
Mattsson, Johanna Sofia Margareta
Botling, Johan
Micke, Patrick
Strell, Carina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-020-02825-z
- URN
-
urn:nbn:de:101:1-2021040307540472298632
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:51 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goldmann, Torsten
- Marwitz, Sebastian
- Nitschkowski, Dörte
- Krupar, Rosemarie
- Backman, Max
- Elfving, Hedvig
- Thurfjell, Viktoria
- Lindberg, Amanda
- Brunnström, Hans
- Fleur, Linnea La
- Mezheyeuski, Artur
- Mattsson, Johanna Sofia Margareta
- Botling, Johan
- Micke, Patrick
- Strell, Carina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 expression in papillary renal cell carcinoma
The intracellular signalosome of PD-L1 in cancer cells
PRRX1 upregulates PD-L1 in human mesenchymal stem cells
Base excision repair regulates PD-L1 expression in cancer cells
Mechanisms regulating PD-L1 expression on tumor and immune cells
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
PD-L1 expressing circulating tumour cells in head and neck cancers
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 expression in papillary renal cell carcinoma
The intracellular signalosome of PD-L1 in cancer cells
PRRX1 upregulates PD-L1 in human mesenchymal stem cells
Base excision repair regulates PD-L1 expression in cancer cells
Mechanisms regulating PD-L1 expression on tumor and immune cells
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
PD-L1 expressing circulating tumour cells in head and neck cancers
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 expression in papillary renal cell carcinoma
The intracellular signalosome of PD-L1 in cancer cells
PRRX1 upregulates PD-L1 in human mesenchymal stem cells
Base excision repair regulates PD-L1 expression in cancer cells
Mechanisms regulating PD-L1 expression on tumor and immune cells
STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
PD-L1 expressing circulating tumour cells in head and neck cancers